Palatin Technologies Company Profile (NYSE:PTN)

About Palatin Technologies (NYSE:PTN)

Palatin Technologies logoPalatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company's primary product in clinical development is bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD), which is a type of female sexual dysfunction (FSD) defined as low desire with associated distress. Its other drug development programs include Melanocortin receptor-4 (MC4r), PL-3994 and Melanocortin receptor-1 (MC1r). MC4r is a compound used for treatment of obesity and diabetes. PL-3994 is a subcutaneously injected guanylate-cyclase type A (GC-A) receptor agonist. MC1r agonist peptides are used for treatment of inflammatory and dermatologic disease indications.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NYSE:PTN
  • CUSIP: N/A
  • Web: www.palatin.com/
Capitalization:
  • Market Cap: $95.73 million
  • Outstanding Shares: 152,801,000
Average Prices:
  • 50 Day Moving Avg: $0.46
  • 200 Day Moving Avg: $0.40
  • 52 Week Range: $0.29 - $0.90
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -20.88
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $10.82 million
  • Price / Sales: 8.85
  • Book Value: ($0.13) per share
  • Price / Book: -4.82
Profitability:
  • EBIDTA: ($37,580,000.00)
  • Net Margins: -32.93%
  • Return on Assets: -37.75%
Misc:
  • Average Volume: 1.50 million shs.
  • Short Ratio: 11.26
 

Frequently Asked Questions for Palatin Technologies (NYSE:PTN)

What is Palatin Technologies' stock symbol?

Palatin Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "PTN."

How were Palatin Technologies' earnings last quarter?

Palatin Technologies, Inc. (NYSE:PTN) issued its quarterly earnings results on Thursday, February, 9th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.07) by $0.01. During the same period in the previous year, the business posted ($0.08) earnings per share. View Palatin Technologies' Earnings History.

Where is Palatin Technologies' stock going? Where will Palatin Technologies' stock price be in 2017?

2 brokers have issued 1-year target prices for Palatin Technologies' shares. Their forecasts range from $0.55 to $6.00. On average, they anticipate Palatin Technologies' share price to reach $2.68 in the next twelve months. View Analyst Ratings for Palatin Technologies.

Are investors shorting Palatin Technologies?

Palatin Technologies saw a decrease in short interest during the month of August. As of August 31st, there was short interest totalling 8,349,908 shares, a decrease of 6.7% from the August 15th total of 8,945,568 shares. Based on an average trading volume of 664,635 shares, the short-interest ratio is presently 12.6 days. Approximately 5.8% of the shares of the stock are short sold.

Who are some of Palatin Technologies' key competitors?

Who are Palatin Technologies' key executives?

Palatin Technologies' management team includes the folowing people:

  • John K. A. Prendergast Ph.D., Chairman of the Board
  • Carl Spana Ph.D., President, Chief Executive Officer, Director
  • Stephen T. Wills CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
  • Robert K. deVeer Jr., Independent Director
  • Alan William Dunton M.D., Independent Director
  • Zola P. Horovitz Ph.D., Independent Director
  • J. Stanley Hull, Independent Director
  • Arlene M. Morris, Independent Director

Who owns Palatin Technologies stock?

Palatin Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.66%), California Public Employees Retirement System (0.32%) and Sphera Funds Management LTD. (0.31%). Company insiders that own Palatin Technologies stock include Joseph Stanley Hull and Robert K Deveer Jr. View Institutional Ownership Trends for Palatin Technologies.

Who sold Palatin Technologies stock? Who is selling Palatin Technologies stock?

Palatin Technologies' stock was sold by a variety of institutional investors in the last quarter, including Sphera Funds Management LTD. and Vanguard Group Inc.. View Insider Buying and Selling for Palatin Technologies.

How do I buy Palatin Technologies stock?

Shares of Palatin Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Palatin Technologies' stock price today?

One share of Palatin Technologies stock can currently be purchased for approximately $0.63.


MarketBeat Community Rating for Palatin Technologies (NYSE PTN)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  232
MarketBeat's community ratings are surveys of what our community members think about Palatin Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Palatin Technologies (NYSE:PTN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.68 (328.31% upside)

Analysts' Ratings History for Palatin Technologies (NYSE:PTN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/10/2017Canaccord GenuitySet Price TargetBuy$6.00HighView Rating Details
1/25/2017Roth CapitalReiterated RatingBuy$1.50N/AView Rating Details
9/22/2016S&P Equity ResearchLower Price Target$0.61 -> $0.55N/AView Rating Details
(Data available from 9/20/2015 forward)

Earnings

Earnings History for Palatin Technologies (NYSE:PTN)
Earnings by Quarter for Palatin Technologies (NYSE:PTN)
Earnings History by Quarter for Palatin Technologies (NYSE PTN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/18/2017Q3 2017$0.10($0.02)$60.00 million$10.82 millionViewN/AView Earnings Details
2/9/2017Q2 2017($0.07)($0.06)ViewListenView Earnings Details
11/15/2016Q117($0.08)($0.08)ViewN/AView Earnings Details
9/20/2016Q416($0.08)($0.09)ViewListenView Earnings Details
5/17/2016Q316($0.08)($0.08)ViewN/AView Earnings Details
2/16/2016Q216($0.07)($0.08)ViewN/AView Earnings Details
11/12/2015Q116($0.08)($0.08)ViewListenView Earnings Details
9/21/2015Q415($0.06)($0.09)$2.05 million$12.95 millionViewListenView Earnings Details
5/13/2015Q315($0.04)($0.07)$0.41 millionViewListenView Earnings Details
2/13/2015Q115$0.01$0.03$5.40 million$4.90 millionViewN/AView Earnings Details
11/18/2014Q1 15$0.04$0.01$9.00 million$4.93 millionViewN/AView Earnings Details
9/9/2014Q4 14$0.03($0.04)ViewN/AView Earnings Details
5/13/2014Q3($0.03)($0.01)$500.00 millionViewListenView Earnings Details
11/14/2013Q1($0.05)($0.04)ViewListenView Earnings Details
10/1/2013Q413($0.05)($0.04)ViewListenView Earnings Details
5/14/2013Q3 2013($0.05)($0.04)$0.02 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Palatin Technologies (NYSE:PTN)
Current Year EPS Consensus Estimate: $-0.1400 EPS
Next Year EPS Consensus Estimate: $-0.0300 EPS

Dividends

Dividend History for Palatin Technologies (NYSE:PTN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Palatin Technologies (NYSE:PTN)
Insider Trades by Quarter for Palatin Technologies (NYSE:PTN)
Institutional Ownership by Quarter for Palatin Technologies (NYSE:PTN)
Insider Trades by Quarter for Palatin Technologies (NYSE:PTN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/4/2015Joseph Stanley HullDirectorBuy2,500$0.66$1,650.00View SEC Filing  
10/2/2015Robert K Deveer JrDirectorBuy10,000$0.82$8,200.00View SEC Filing  
2/26/2014Bvf Partners L P/IlMajor ShareholderSell540,181$1.14$615,806.34View SEC Filing  
2/19/2014Bvf Partners L P/IlMajor ShareholderSell305,966$1.17$357,980.22View SEC Filing  
3/19/2013Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
2/1/2013Alan W DuntonDirectorBuy2,000$0.59$1,180.00View SEC Filing  
1/28/2013Robert I TaberDirectorBuy5,000$0.59$2,950.00View SEC Filing  
12/31/2012Carl SpanaCEOBuy10,000$0.57$5,700.00View SEC Filing  
12/28/2012Stephen T WillsCFOBuy10,000$0.56$5,600.00View SEC Filing  
12/24/2012Perry B MolinoffDirectorBuy10,000$0.61$6,100.00View SEC Filing  
12/14/2012Robert K Deveer JrDirectorBuy21,960$0.70$15,372.00View SEC Filing  
9/4/2012Alan W DuntonDirectorBuy1,000$0.58$580.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Palatin Technologies (NYSE:PTN)
Latest Headlines for Palatin Technologies (NYSE:PTN)
Source:
DateHeadline
prnewswire.com logoPalatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors - PR Newswire (press release)
www.prnewswire.com - September 14 at 9:30 AM
americanbankingnews.com logoPalatin Technologies, Inc. (PTN) Sees Significant Drop in Short Interest
www.americanbankingnews.com - September 13 at 1:26 AM
finance.yahoo.com logoPalatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors
finance.yahoo.com - September 12 at 8:54 AM
americanbankingnews.com logoCanaccord Genuity Reiterates "$6.00" Price Target for Palatin Technologies, Inc. (PTN)
www.americanbankingnews.com - September 11 at 8:24 PM
prnewswire.com logoPalatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in ... - PR Newswire (press release)
www.prnewswire.com - September 8 at 7:19 AM
streetinsider.com logoPre-Open Stock Movers 09/06: (VSTM) (VYGR) (SRPT) Higher; (TRVG) (RXDX) (FRAN) Lower (more...)
www.streetinsider.com - September 7 at 7:54 AM
finance.yahoo.com logoPalatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected Territories
finance.yahoo.com - September 7 at 7:54 AM
americanbankingnews.com logoPalatin Technologies, Inc. (PTN) Sees Large Decrease in Short Interest
www.americanbankingnews.com - August 25 at 1:26 AM
americanbankingnews.com logoPalatin Technologies, Inc. (NYSE:PTN) Short Interest Update
www.americanbankingnews.com - August 9 at 7:26 PM
americanbankingnews.com logoPalatin Technologies, Inc. (NYSE:PTN) Downgraded by Zacks Investment Research
www.americanbankingnews.com - July 29 at 8:36 AM
americanbankingnews.com logoPalatin Technologies, Inc. (PTN) Sees Large Increase in Short Interest
www.americanbankingnews.com - June 26 at 7:00 PM
americanbankingnews.com logoShort Interest in Palatin Technologies, Inc. (PTN) Increases By 7.8%
www.americanbankingnews.com - June 9 at 5:18 PM
prnewswire.com logoStock Performance Review on Healthcare Sector -- Palatin Technologies, Centene, Anthem, and AMAG Pharma
www.prnewswire.com - June 8 at 8:59 AM
americanbankingnews.com logoPalatin Technologies, Inc. (PTN) Earns Buy Rating from Canaccord Genuity
www.americanbankingnews.com - June 1 at 7:28 PM
americanbankingnews.com logoPalatin Technologies, Inc. (PTN) Short Interest Update
www.americanbankingnews.com - May 24 at 6:58 PM
americanbankingnews.com logoPalatin Technologies, Inc. (PTN) PT Set at $6.00 by Canaccord Genuity
www.americanbankingnews.com - May 17 at 7:10 PM
americanbankingnews.com logoPalatin Technologies, Inc. (PTN) Announces Earnings Results
www.americanbankingnews.com - May 17 at 10:02 AM
prnewswire.com logoPalatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 ... - PR Newswire (press release)
www.prnewswire.com - May 17 at 12:05 AM
finance.yahoo.com logoEdited Transcript of PTN earnings conference call or presentation 16-May-17 3:00pm GMT
finance.yahoo.com - May 17 at 12:05 AM
rttnews.com logoEARNINGS SUMMARY: Details of Palatin Technologies Inc. Q3 Earnings Report
www.rttnews.com - May 16 at 7:03 PM
finance.yahoo.com logoPalatin Technologies, Inc. Reports Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017
finance.yahoo.com - May 16 at 9:44 AM
finance.yahoo.com logoPalatin Technologies, Inc. to Report Third Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on May 16, 2017
finance.yahoo.com - May 11 at 8:27 AM
americanbankingnews.com logoPalatin Technologies (PTN) Receives Daily Media Sentiment Score of 0.10
www.americanbankingnews.com - April 29 at 11:57 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Very Likely to Affect Palatin Technologies (PTN) Share Price
www.americanbankingnews.com - April 26 at 9:34 PM
americanbankingnews.com logoPalatin Technologies (PTN) Earns Daily News Impact Rating of 0.17
www.americanbankingnews.com - April 18 at 12:57 AM
americanbankingnews.com logoShort Interest in Palatin Technologies, Inc. (PTN) Increases By 1.2%
www.americanbankingnews.com - April 11 at 7:36 PM
finance.yahoo.com logoPalatin Technologies to Present at The MicroCap Conference on April 4th at 1:00 PM ET in New York City at the Essex House
finance.yahoo.com - March 31 at 7:32 PM
americanbankingnews.com logoCanaccord Genuity Reiterates $6.00 Price Target for Palatin Technologies, Inc. (PTN)
www.americanbankingnews.com - March 26 at 9:46 PM
americanbankingnews.com logoShort Interest in Palatin Technologies, Inc. (PTN) Declines By 2.3%
www.americanbankingnews.com - March 25 at 7:14 AM
streetinsider.com logoPalatin Technologies (PTN) Reports Methods of Use Patent for Treatment of HSDD in Premenopausal Women - StreetInsider.com
www.streetinsider.com - March 23 at 12:21 AM
finance.yahoo.com logoPalatin Technologies Receives Notice of Allowance on Bremelanotide Methods of Use Patent for Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women
finance.yahoo.com - March 20 at 9:26 AM
finance.yahoo.com logo7:31 am Palatin Technologies announces that the USPTO has issued a NOA for U.S. Patent Application Serial Number 14/704,223 for the treatment of hypoactive sexual desire disorder in premenopausal women
finance.yahoo.com - March 20 at 9:26 AM
bizjournals.com logoHealthcare Stocks on Investors' Radar -- Delcath Systems, Palatin Technologies, AMAG Pharma, and IDEXX Laboratories
www.bizjournals.com - March 14 at 10:04 AM
americanbankingnews.com logoShort Interest in Palatin Technologies, Inc. (PTN) Grows By 22.0%
www.americanbankingnews.com - March 9 at 6:30 PM
streetinsider.com logoAMAG Pharma (AMAG), Palatin (PTN) Announce Rekynda Data Presentations at ISSWSH Meeting
www.streetinsider.com - February 27 at 4:13 PM
nasdaq.com logoAMAG, Palatin Say Both Phase 3 RECONNECT Studies Met Co-primary End Points
www.nasdaq.com - February 27 at 9:41 AM
finance.yahoo.com logoAMAG and Palatin Announce Rekynda™ Data Presentations at the International Society for the Study of Women’s Sexual Health Annual Meeting
finance.yahoo.com - February 27 at 9:41 AM
investopedia.com logoAMAG Inks $60M Women's Health Drug Deal (AMAG)
www.investopedia.com - February 16 at 6:59 PM
finance.yahoo.com logoPALATIN TECHNOLOGIES INC Financials
finance.yahoo.com - February 16 at 6:59 PM
biz.yahoo.com logoPALATIN TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - February 10 at 9:45 PM
rttnews.com logoEARNINGS SUMMARY: Details of Palatin Technologies Inc. Q2 Earnings Report
www.rttnews.com - February 10 at 3:11 AM
seekingalpha.com logoPalatin Technologies' (PTN) CEO Carl Spana on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 9 at 10:08 PM
biz.yahoo.com logoQ2 2017 Palatin Technologies Inc Earnings Release - Before Market Open
biz.yahoo.com - February 9 at 10:08 PM
finance.yahoo.com logoPalatin Technologies, Inc. Reports Second Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on February 9, 2017
finance.yahoo.com - February 9 at 10:08 PM
biz.yahoo.com logoPALATIN TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - February 9 at 10:08 PM
biz.yahoo.com logoPALATIN TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - February 8 at 9:32 PM
streetinsider.com logoPalatin Technologies (PTN) Closes License Agreement for Rekynda Rights with AMAG Pharmaceuticals (AMAG)
www.streetinsider.com - February 3 at 8:14 PM
finance.yahoo.com logoPalatin (PTN) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - February 2 at 9:11 PM

Social

Chart

Palatin Technologies (PTN) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by MarketBeat.com Staff